+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06357091

Comparison of Human Allograft Cortical Bone Screw and Biocomposite Interference Screws for ACL Reconstruction A Prospective Randomized Controlled Trial Measuring Bone Tunnel Widening and Knee Function

Led by Alexander Rofner-Moretti · Updated on 2026-01-21

80

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This trial studies adults with anterior cruciate ligament ACL rupture who need reconstructive surgery. It compares two types of screws used for fixing the graft during ACL reconstruction a human allogeneic cortical bone screw called Shark Screw ACL and a conventional biocomposite screw Mecta. The goal is to see if the bone screw reduces bone tunnel widening and lowers the rate of graft re-rupture. Knee function scores before and after surgery are also recorded to assess outcomes. Participants undergo ACL reconstruction with either the allogeneic bone screw or the biocomposite screw. The surgical technique is the same for both groups, including arthroscopic confirmation of diagnosis, tendon preparation, bone tunnel creation, graft insertion, and fixation with the assigned interference screw. The tibial bone tunnel is filled with cancellous chips, and graft stability is checked before wound closure. Participants have MRIs before surgery, within 3 days after surgery, and at 6, 12, and 24 months post-surgery. CT scans are done immediately after surgery, and at 6 and 24 months. Knee scores IKDC, KOOS, Lysholm, Tegner are collected before surgery and at 6, 12, and 24 months. The study measures bone tunnel widening in millimeters over time and evaluates graft incorporation, safety, and knee function. Total participation lasts 24 months after surgery.

CONDITIONS

Brief Title

ACL Reconstruction With Shark Screw® or Biocomposite-interference Screws

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • MRI-verified rupture of the anterior cruciate ligament
  • Indication for replacement surgery
  • Surgery within 6 months of injury
  • Uninjured contralateral knee
Not Eligible

You will not qualify if you...

  • Previous rupture of the anterior cruciate ligament on the side to be operated on (rerupture)
  • Primary bone disease
  • Inflammatory disease
  • Unstable meniscus
  • Complete rupture of a collateral ligament
  • Early rerupture during the examination period (early rerupture)

Research Team

A

Alexander Rofner-Moretti, MD

M

Markus Reichkendler, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here